Core Viewpoint - The brain-computer interface (BCI) industry is entering a rapid growth phase, with the global market expected to reach approximately $12.4 billion by 2034, reflecting a compound annual growth rate (CAGR) of 17.35% [4] Group 1: Market Overview - The BCI market is experiencing significant advancements due to the integration of technologies such as artificial intelligence, flexible materials, and biosensors [4] - Strong Brain Technology, one of the "Six Little Dragons" in Hangzhou, has completed a Pre-B round of financing, achieving a post-investment valuation exceeding $1.3 billion, positioning it as a leading unicorn in the domestic BCI sector [4][7] Group 2: Technological Directions - There are two main technological directions in the BCI field: invasive and non-invasive. Invasive technologies, represented by Neuralink, involve surgical implantation of electrodes, offering high signal quality but facing high costs and ethical concerns [5] - Non-invasive technologies, exemplified by Strong Brain Technology, do not require surgery and are more suitable for large-scale applications, primarily used in rehabilitation training and seen as having greater commercial potential [5] Group 3: Product Development and Controversies - Strong Brain Technology is developing a product akin to an "electronic version of semaglutide," aimed at reducing appetite to assist with weight loss, which has sparked discussions about the boundaries of consumer applications for BCI [7] - The company's product portfolio spans three main areas: smart bionics, smart health, and smart education, including devices like bionic hands and legs, sleep devices, and attention training systems [7] Group 4: Technological Accumulation - Strong Brain Technology has developed a proprietary solid-state gel electrode known as the "super sensor," capable of high-precision collection of brain and muscle electrical signals [8] - The company has secured over 460 authorized patents, with more than 250 core invention patents, placing it among the leaders in the global BCI industry [8]